RNL-Astrostem®, adipose-derived mesenchymal stem cells for treatment of peripheral vascular diseases

RNL-Astrostem® are autologous adipose-derived mesenchymal stem cells (Adipose-MSCs) used for treatment of a wide range of diseases. The purpose of these studies is to assess the efficacy and safety of autologous transplantation of adipose-MSCs in patients with critical limb ischemia and in patients with Buerger's disease (peripheral vascular diseases).